Susquehanna International Group
IMGN

Susquehanna International Group’s Immunogen Inc IMGN Stock Holding History

Susquehanna International Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-736,034
Closed -$21.8M – 13802
2023
Q4 		$21.8M Sell
736,034
-238,853
-25% -$4.76M ﹤0.01% 1718
2023
Q3 		$15.5M Sell
974,887
-340,771
-26% -$5.67M ﹤0.01% 2041
2023
Q2 		$24.8M Buy
1,315,658
+656,842
+100% +$7.76M 0.01% 1522
2023
Q1 		$2.53M Buy
658,816
+334,180
+103% +$1.42M ﹤0.01% 4656
2022
Q4 		$1.61M Sell
324,636
-250,003
-44% -$1.36M ﹤0.01% 5131
2022
Q3 		$2.75M Buy
574,639
+318,022
+124% +$1.68M ﹤0.01% 4262
2022
Q2 		$1.16M Sell
256,617
-139,068
-35% -$604K ﹤0.01% 6169
2022
Q1 		$1.88M Sell
395,685
-65,621
-14% -$363K ﹤0.01% 5611
2021
Q4 		$3.42M Buy
461,306
+200,285
+77% +$1.24M ﹤0.01% 4420
2021
Q3 		$1.48M Buy
261,021
+4,474
+2% +$25.9K ﹤0.01% 6523
2021
Q2 		$1.69M Buy
256,547
+110,470
+76% +$771K ﹤0.01% 6309
2021
Q1 		$1.18M Buy
146,077
+103,366
+242% +$844K ﹤0.01% 7273
2020
Q4 		$275K Sell
42,711
-59,397
-58% -$346K ﹤0.01% 9437
2020
Q3 		$367K Buy
102,108
+10,277
+11% +$41.5K ﹤0.01% 8310
2020
Q2 		$423K Sell
91,831
-88,810
-49% -$378K ﹤0.01% 7723
2020
Q1 		$616K Buy
180,641
+120,616
+201% +$527K ﹤0.01% 6477
2019
Q4 		$306K Sell
60,025
-318,584
-84% -$1.08M ﹤0.01% 7973
2019
Q3 		$916K Sell
378,609
-481,305
-56% -$1.28M ﹤0.01% 5864
2019
Q2 		$1.87M Sell
859,914
-140,544
-14% -$332K ﹤0.01% 4310
2019
Q1 		$2.71M Sell
1,000,458
-74,839
-7% -$324K ﹤0.01% 3293
2018
Q4 		$5.16M Buy
+1,075,297
New +$6.52M ﹤0.01% 2255
2018
Q3 		– Sell
-204,474
Closed -$1.97M – 10466
2018
Q2 		$1.99M Buy
+204,474
New +$2.16M ﹤0.01% 4032
2017
Q4 		– Sell
-17,209
Closed -$106K – 10072
2017
Q3 		$132K Buy
+17,209
New +$114K ﹤0.01% 8258
2017
Q1 		– Sell
-441,184
Closed -$1.29M – 10222
2016
Q4 		$900K Buy
441,184
+407,600
+1,214% +$818K ﹤0.01% 5752
2016
Q3 		$90K Buy
+33,584
New +$97.7K ﹤0.01% 7978
2016
Q2 		– Sell
-163,191
Closed -$1.02M – 9509
2016
Q1 		$1.39M Buy
163,191
+118,307
+264% +$1M ﹤0.01% 4442
2015
Q4 		$609K Sell
44,884
-67,788
-60% -$834K ﹤0.01% 6387
2015
Q3 		$1.08M Buy
112,672
+82,596
+275% +$1.21M ﹤0.01% 5585
2015
Q2 		$432K Sell
30,076
-104,320
-78% -$1.15M ﹤0.01% 7907
2015
Q1 		$1.2M Sell
134,396
-323,880
-71% -$2.35M ﹤0.01% 5373
2014
Q4 		$2.79M Buy
458,276
+371,500
+428% +$3.4M ﹤0.01% 3855
2014
Q3 		$919K Sell
86,776
-43,236
-33% -$489K ﹤0.01% 6089
2014
Q2 		$1.54M Buy
130,012
+4,358
+3% +$54.7K ﹤0.01% 5165
2014
Q1 		$1.88M Buy
125,654
+35,858
+40% +$565K ﹤0.01% 4452
2013
Q4 		$1.32M Buy
89,796
+1,088
+1% +$16.7K ﹤0.01% 4993
2013
Q3 		$1.51M Buy
88,708
+71,538
+417% +$1.26M ﹤0.01% 4585
2013
Q2 		$285K Buy
+17,170
New +$278K ﹤0.01% 6881

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's IMGN Position: Q1 2024 in Review

Susquehanna International Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 736,034 shares — an estimated $21.8M sold.

Susquehanna International Group first reported a position in IMGN in Q2 2013 and held it in 37 quarters. The position peaked at $24.8M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Susquehanna International Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 736,034 Immunogen Inc shares in Q1 2024, an estimated $21.8M.
  • Susquehanna International Group first reported a position in Immunogen Inc in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Immunogen Inc position peaked at $24.8M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.